Black Diamond Therapeutics (BDTX) Other Non-Current Assets: 2018-2020

Historic Other Non-Current Assets for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $1.2 million.

  • Black Diamond Therapeutics' Other Non-Current Assets changed negligibly% to $1.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.2 million for FY2020, which is 46.90% down from last year.
  • According to the latest figures from FY2020, Black Diamond Therapeutics' Other Non-Current Assets is $1.2 million, which was down 46.90% from $2.3 million recorded in FY2019.
  • Black Diamond Therapeutics' Other Non-Current Assets' 5-year high stood at $2.3 million during FY2019, with a 5-year trough of $8,000 in FY2018.
  • Its 3-year average for Other Non-Current Assets is $1.2 million, with a median of $1.2 million in 2020.
  • In the last 5 years, Black Diamond Therapeutics' Other Non-Current Assets surged by 28,687.50% in 2019 and then crashed by 46.90% in 2020.
  • Over the past 3 years, Black Diamond Therapeutics' Other Non-Current Assets (Yearly) stood at $8,000 in 2018, then soared by 28,687.50% to $2.3 million in 2019, then tumbled by 46.90% to $1.2 million in 2020.